logo

Corvus Pharmaceuticals, Inc. (CRVS)



Trade CRVS now with
  Date
  Headline
5/13/2019 6:29:37 AM Wedbush Is Lowering Corvus Pharmaceuticals, Inc. (CRVS) FY19 Estimate To -1.76 From -1.72
5/13/2019 6:28:27 AM Wedbush Is Cutting Corvus Pharmaceuticals, Inc. (CRVS) Q4 19 Estimate To -0.48 From -0.47
5/13/2019 6:28:14 AM Wedbush Is Cutting Corvus Pharmaceuticals, Inc. (CRVS) Q3 19 Estimate To -0.45 From -0.44
5/13/2019 6:28:01 AM Wedbush Is Cutting Corvus Pharmaceuticals, Inc. (CRVS) Q2 19 Estimate To -0.42 From -0.41
11/5/2018 6:52:36 AM Wedbush Is Raising Corvus Pharmaceuticals, Inc. (CRVS) FY18 Estimate To -1.81 From -2.02
11/5/2018 6:52:22 AM Wedbush Is Raising Corvus Pharmaceuticals, Inc. (CRVS) Q4 18 Estimate To -0.41 From -0.52
8/8/2018 8:58:44 AM Wedbush Is Raising Corvus Pharmaceuticals, Inc. (CRVS) FY18 Estimate To -2.02 From -2.61
8/8/2018 8:57:51 AM Wedbush Is Increasing Corvus Pharmaceuticals, Inc. (CRVS) Q4 18 Estimate To -0.52 From -0.73
8/8/2018 8:57:29 AM Wedbush Is Increasing Corvus Pharmaceuticals, Inc. (CRVS) Q3 18 Estimate To -0.47 From -0.66
5/7/2018 4:43:07 PM Wedbush Is Raising Corvus Pharmaceuticals, Inc. (CRVS) FY18 Estimate To -2.61 From -3.09
5/7/2018 4:42:42 PM Wedbush Is Raising Corvus Pharmaceuticals, Inc. (CRVS) Q2 18 Estimate To -0.59 From -0.84
8/2/2017 7:22:57 PM Wedbush Starts Corvus Pharmaceuticals, Inc. (CRVS) At Outperform With $26.00 Price Target